Since 2011, our concert proceeds, together with contributions from our partners, have been invested in over $3.6 million in leading edge research to detect and cure lung cancer, the #1 cancer killer.
We invest in cutting-edge diagnostic research to find lung cancer early and change the 5-year survival rate from 19% to 57%.
The Voice Blog
Why People with Lung Cancer Need Biomarker Testing – and Why They Aren’t Getting It
In recent years there is renewed hope for treatment of lung cancer using precision medicine. Knowing your biomarker can guide a specific therapeutic treatment plan that aims precisely at that mutation. So,why do only 50% of patients with advanced lung cancer get their tumors tested for biomarkers?